711 related articles for article (PubMed ID: 19273538)
1. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
2. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Boffa MJ; Smith A; Chalmers RJ
Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
[No Abstract] [Full Text] [Related]
4. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
[TBL] [Abstract][Full Text] [Related]
5. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
[TBL] [Abstract][Full Text] [Related]
6. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
7. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
8. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
Nyfors A; Poulsen H
Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
[TBL] [Abstract][Full Text] [Related]
9. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
[TBL] [Abstract][Full Text] [Related]
10. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
Mathew J; Leong MY; Morley N; Burt AD
BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
[TBL] [Abstract][Full Text] [Related]
11. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
Zachariae H; Heickendorff L; Søgaard H
Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
Gilbert SC; Klintmalm G; Menter A; Silverman A
Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
[TBL] [Abstract][Full Text] [Related]
13. Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?
Lindsay K; Gough A
Rheumatology (Oxford); 2008 Jul; 47(7):939-41. PubMed ID: 18474510
[No Abstract] [Full Text] [Related]
14. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
Minocha A; Dean HA; Pittsley RA
Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic arthritis: clinical response and side effects to methotrexate therapy.
Espinoza LR; Zakraoui L; Espinoza CG; Gutiérrez F; Jara LJ; Silveira LH; Cuéllar ML; Martínez-Osuna P
J Rheumatol; 1992 Jun; 19(6):872-7. PubMed ID: 1404123
[TBL] [Abstract][Full Text] [Related]
16. Drug use and toxicity in psoriatic disease: focus on methotrexate.
Taylor WJ; Korendowych E; Nash P; Helliwell PS; Choy E; Krueger GG; Soriano ER; McHugh NJ; Rosen CF
J Rheumatol; 2008 Jul; 35(7):1454-7. PubMed ID: 18609744
[TBL] [Abstract][Full Text] [Related]
17. Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency.
Mathew J; Igbokwe UO; Morley N; Burt AD
Dermatology; 2006; 213(2):147-9. PubMed ID: 16902293
[TBL] [Abstract][Full Text] [Related]
18. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
[TBL] [Abstract][Full Text] [Related]
19. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
